Befiradol-Impurities | Pharmaffiliates

befiradol and its Impurities

Befiradol was discovered and developed by Pierre Fabre Médicament, a French pharmaceuticals company.It is an experimental drug being studied for the treatment of levodopa-induced dyskinesia. Reference standards of Befiradol API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for befiradol Impurities
PA 02 98000

Befiradol - API

Befiradol


  • Catalogue No.:PA 02 98000

  • CAS :

    208110-64-9

  • Molecular Formula : C20H22ClF2N3O

  • Molecular Weight : 393.86